Down-regulation of phosphoglucomutase 3 mediates sulforaphane-induced cell death in LNCaP prostate cancer cells
- Chan-Hee Lee†1,
- Soo-Jin Jeong†1,
- Sun-Mi Yun1,
- Ji-Hyun Kim1,
- Hyo-Jung Lee1,
- Kwang Seok Ahn1,
- Suk-Hyun Won1,
- Hyun Seok Kim2,
- Hyo-Jeong Lee1,
- Kyoo-Seok Ahn1,
- Shudong Zhu3,
- Chang-Yan Chen3 and
- Sung-Hoon Kim1Email author
© Lee et al; licensee BioMed Central Ltd. 2010
Received: 10 August 2010
Accepted: 16 December 2010
Published: 16 December 2010
Sulforaphane (SFN) is an isothiocyanate found in cruciferous vegetables that exerts anti-oxidant, anti-inflammatory, anti-cancer and radio-sensitizing activities. Nonetheless, the mechanism responsible for SFN-induced cell death is not fully understood. In the present study, anti-cancer mechanism of SFN was elucidated in LNCaP prostate cancer cells.
SFN exerted cytotoxicity and increased TUNEL positive cells in a concentration-dependent manner in LNCaP cells. Proteomics study revealed that levels of nine proteins including tubulin β-2, phosphoglucomutase-3 (PGM3), melanoma-derived leucine zipper containing extra-nuclear factor, activin A type I receptor precursor, smoothelin-A, KIA0073, hypothetical protein LOC57691 and two unnamed proteins were changed over 8 folds in SFN treated LNCaP cells compared to untreated control. We have further confirmed that SFN reduced PGM3 expression with western blotting and showed that PGM3 siRNA enhanced cytotoxicity demonstrated by cell morphology and TUNEL assays in LNCaP cells.
Taken together, these findings suggest that PGM3 plays a role in mediating SFN-induced cell death in LNCaP cells, and is a potential molecular therapeutic target for prostate cancer.
Cell death is defined as an irreversible loss of plasma membrane integrity. Historically, three types of cell death have been distinguished in mammalian cells by morphological criteria, namely apoptosis, autophagy and necrosis . Apoptosis represents a major regulatory mechanism that eliminates abundant and unwanted cells during embryonic development, growth, differentiation and normal cell turnover [2, 3]. Recently, targeting apoptosis is thought to be a potential therapeutic approach for cancer treatment.
Prostate cancer develops in nearly 30% of all men above the age of 50 years  and may metastasize to other parts of the human body, especially bones and lymph nodes. Many chemotherapeutic agents such as Eulexin, Flutamide and Nilandron have been developed for the treatment of prostate cancer. However, undesirable side effects such as urinary incontinence and erectile dysfunction can reduce the therapeutic efficacy of prostate cancer. In this regard, recent reports have reported the possibility to use natural compounds as chemopreventive candidates by inducing apoptotic cell death in prostate cancer cells [5–9].
Sulforaphane (SFN) (Additional file 1: figure S1) is a breakdown product of Glucoraphanin which is the compound present in cruciferous vegetables . Many groups reported that SFN induced apoptosis though activation of caspase-3 and cell cycle arrest in prostate cancer cells [11, 12]. However, its exact molecular mechanisms whereby SFN mediates apoptosis are not fully understood. Thus, in the present study, anti-cancer mechanisms of SFN to induce apoptosis were investigated by a comparative proteomic analysis. We here demonstrate that phosphoglucomutase-3 (PGM3) plays a role in the regulation of SFN-induced apoptosis in LNCaP prostate cancer cells.
Sulforaphane exerts cytotoxicity and induces apoptosis in LNCaP cells
Differential protein profiles of SFN-treated and -untreated LNCaP cells
Effect of SFN on the significantly changed protein expressions
NCBI accession No.
Expression of SFN-treated LNCaP cells
Tubulin, beta 2
unnamed protein product
Melanoma-derived leucine zipper, extra-nuclear factor
unnamed protein product
Activin-A type I receptor precursor
hypothetical protein LOC57691
Phosphoglucomutase 3 is involved in SFN-induced apoptosis in LNCaP cells
To examine whether PGM3 is related to SFN-induced apoptosis in LNCaP cells, cell death was analyzed in LNCaP cells transfected with PGM3 siRNA in the absence or presence of SFN. Western blotting shown in Figure 4B revealed that PGM3 siRNA clearly suppressed PGM3 protein expression, while control siRNA did not affect PGM3 expression. Also, PGM3 siRNA transfection effectively inhibited the growth of LNCaP cells compared with siRNA control (Figure 4C). As shown in Figure 4D, morphological changes and growth inhibition were observed in LNCaP cells transfected by PGM3 siRNA under inverted microscopy. Furthermore, co-treatment with SFN and PGM3 siRNA synergistically increased the number of TUNEL-positive cells (Figure 4E), suggesting that PGM3 may be involved in mediating SFN-induced cell death in LNCaP cells.
Foods of cruciferous vegetables such as broccoli, cabbage, and kale are known for their anti-cancer activities against various types of cancers [13–17]. The anti-cancer effects of cruciferous vegetables were reported to be mainly due to the high levels of glucosinolates, which, following hydrolysis by the enzyme myrosinase, result in the formation of isothiocyanates [10, 16]. Of the isothiocynates, SFN is an effective chemoprotective agent in carcinogen-induced animal models [18–20], and xenograft models of prostate cancer . Recent works also showed the multifunctional action of SFN as Phase 2 enzyme inducer, cell cycle arrest and apoptosis [22–26].
Prostate cancer is the second leading cause of cancer-related death in men. Prostate adenocarcinoma is considered a disease of older men. However, almost one third of these men harbor evidence of the disease (high-grade prostatic intraepithelial neoplasia) between the age of 30 and 40 years. Epidemiological studies suggest that cruciferous vegetable intake may lower overall risk of prostate cancer, particularly during the early stages [27–30]; hence there are growing interests in identifying the specific chemopreventive agents from medicinal plants and in elucidating their mechanisms.
There are evidences that SFN can be a cancer preventive candidate for prostate cancer treatment. Herman-Antosiewicz et al. demonstrated that SFN-induced p21 protein protects against SFN-induced mitotic arrest in LNCaP prostate cancer cells . Cho et al. demonstrated that SFN mediated the activation of c-Jun N-terminal kinase and caspase-mediated apoptosis in DU145 prostate cancer cells . Nonetheless, the mechanisms of SFN in LNCaP prostate cancer cells still remain unveiled. Thus, in the present study, we investigated anti-cancer mechanisms of SFN in LNCaP cells by protemic analysis. SFN exerted cytotoxicity against LNCaP cells in a concentration-dependent manner with IC50 of ~62.5 μM (Figure 2A). Consistent with the results of previous reports [12, 32], SFN increased DNA fragmentation, a hallmark of apoptosis, in TUNEL assay (Figure 2C) and cleaved PARP and activated caspase-3 (data not shown), suggesting the apoptotic effects of SFN in LNCaP cells.
Proteomics is the high-throughtput, large-scale, mainly automated analysis of protein mixtures to determine the expression level and post-translational modification of the proteins . Proteomic analysis was performed to evaluate the mechanism of SFN-induced cell death in LNCaP cells. Nine protein spots from a total of ~1800 protein spots were selected for further study due to their most significant changes between SFN-treated group and untreated control in LNCaP cells. Three proteins were significantly down-regulated, including tubulin β-2 (NP_006079), phosphoglucomutase 3 (CAI22635) and unnamed protein product (BAB85079). In contrast, six proteins were significantly up-regulated, including melanoma-derived leucine zipper, extra-nuclear factor (AAH63595), activin A type I receptor precursor (NP_001096), smoothelin-A (AAF03563), KIAA0073 (BAA07555), hypothetical protein LOC57691 (NP_065982) and unnamed protein product (BAC03859) (Figure 3B and Table 1).
Of these proteins, tubulin β-2, a member of tubulin protein which is a major component of the cytoskeleton, was known to be targeted in chemotherapeutic agents such as taxane and Vinca alkaloid-induced apoptosis in cancer cells [34, 35]. Smoothelin is a cytoskeletal protein which is generally found in smooth muscle cells  and consists of isoforms smoothelin-A and -B. Smoothelin-A was reported to be increased in expression in smooth muscle cells in apoptosis induced by pre-B-cell colony- enhancing factor (PBEF) . These reports are consistent with our proteomics observations on these two proteins, and also support our proteomics identification of PGM3 as a mediator of apoptosis.
PGM3 is a member of the hexose-phosphate mutase family and essentially functions in glycogenolysis and glycogenesis . In normal prostate cells, androgen withdrawal induces apoptosis and develops to prostate cancer . However, considering that androgen metabolism is associated with the regulation of glycolytic enzymes and pentose-phosphate pathway , Pang's report that PGM3 converts glucose-1-phosphate to glucose-6-phosphate and mediates glycolysis as well as pentose phosphate shunt  suggests the possible involvement of PGM3 in prostate cancer metabolism. In light of these events, we considered that PGM3 may play a role in the regulation of prostate cancer cell survival. Our Western blotting results demonstrated that SFN significantly decreased the expression of PGM3 in a concentration-dependent manner in LNCaP cells and clearly suppressed at 80 μM of concentration (Figure 4A). According to Gasper and Pledgie-Tracy's studies, SFN can reach at high concentration to human prostate tissues physiologically and be restrained in various tissues including prostate [41, 42]. Consistent with the results of Western blotting, TUNEL assay revealed that PGM3 siRNA increased green fluorescence TUNEL positive cells and also enhanced SFN induced apoptosis compared with control siRNA (Figure 4D). These data and previous reports suggest that PGM3 mediates SFN induced cell death in LNCaP cells, possibly via cancer metabolism.
In summary, SFN effectively activated caspase-3 and increased TUNEL positive cells in LNCaP cells. Using proteomics analysis, we have identified nine proteins that might be involved in SFN induced apoptosis in LNCaP cells. Among them, we have verified SFN-reduced PGM3 expression, and demonstrated that PGM3 siRNA enhanced cytotoxicity and increased TUNEL positive cells in LNCaP cells compared to control. Our findings suggest that PGM3 is involved in mediating SFN-induced cell death in LNCaP cells and may be a potential molecular target for prostate cancer therapeutics.
L-Sulforaphane (purity ≥ 98%) (Figure 1), urea, thiourea, 3-[(3-cholamidopropy) dimethyammonio]-1-propanesulfonate (CHAPS), dithiothreitol (DTT), benzamidine, Bradford solution, acrylamide, iodoacetamide, bis-acrylamide, sodium dodecyl sulphate (SDS), acetonitrile, trifluoroacetic acid and α-cyano-4-hydroxycinnamic acid were purchased from Sigma-Aldrich Co. (St. Louis, MO). Pharmalyte (pH 3.5-10), IPG DryStrips (pH 4-10 NL, 24 cm) and Modified porcine trypsin (sequencing grade) were from Amersham Biosciences, Genomine Inc. and Promega (Maison, WI), respectively.
LNCaP cells were purchased from the American Type Culture Collection (ATCC) (Manassas, VA) and maintained in RPMI 1640 supplemented with 10% fetal bovine serum (Welgene, Korea), 2 mmol/L L-glutamine, 10 mmol/L HEPES, 1 mmol/L sodium pyruvate and 45 g/L glucose with antibiotics at 37°C in a humidified atmosphere containing 5% CO2.
Two-dimensional polyacrylamide gel electrophoresis (2DE-PAGE)
Cells were treated with or without SFN (80 μM) for 24 h, homogenized using mortor-driven homogenizer (PowerGen125, Fisher Scientific) in lysis buffer (7 M urea, 2 M thiourea containing 4% CHAPS, 1% DTT and 2% pharmalyte, and 1 mM benzamidine) and incubated for 1 h at room temperature. After centrifugation at 15,000× g for 1 h at 15°C, soluble fraction was collected and used for two-dimensional gel electrophoresis. Protein concentration was measured by the Bradford assay.
The first-dimensional isoelectric focusing (IEF) was carried out on Pharmacia Immobiline IPG DryStrip system (Uppsala, Sweden). For the first dimension of electrophoresis, the samples containing 100 μg protein for analysis gels were diluted to 350 μL with a rehydration solution (7 M urea, 2% w/v CHAPS, 50 mM DTT, 0.5% v/v IPG buffer (pH 3-10 nonlinear and pH 4-7 linear), and trace bromophenol blue) before loading onto 17 cm IPG strips (pH 3-10 nonlinear and pH 4-7 linear). IEF was then performed using IPG electrophoresis unit according to the manufacturer's instructions. Thereafter, the strips were equilibrated with a solution (6 M urea, 30% v/v glycerol, 2% w/v SDS, and 50 mM Tris-HCl, pH 8.8), reduced with 1% w/v DTT for 15 min, and alkylated with 2.5% w/v iodoacetamide for 15 min. Strips were then rinsed in electrophoresis buffer (25 mM Tris base, 192 mM glycine, and 0.1% w/v SDS), applied to 11% acrylamide gels, and sealed with melted agarose (0.5% w/v agarose in electrophoresis buffer containing a trace of bromophenol blue). SDS-PAGE was carried out using Hoefer SE 600 vertical chambers and a Tris-glycine buffer (25 mM Tris and 192 mM glycine) containing 0.1% w/v SDS, with initial separation at a constant 10 mA/gel for 30 min followed by 20 mA/gel. The second-dimensional SDS-PAGE was developed until the bromophenol blue dye marker had reached the bottom of the gel. The total run time was typically 4 to 4.5 hours. Gels were fixed in 10% v/v acetic acid, 40% v/v ethanol before sensitization for 30 min in a buffer containing 30% v/v ethanol, 0.2% w/v sodium thiosulphate, and 0.83 M sodium acetate. This was followed by three 15 min washes in deionised water. The proteins were then stained with 0.1% w/v silver nitrate for 20 min, washed twice in deionised water for 1 min, and developed in 2.5% w/v sodium carbonate containing 0.04% v/v formaldehyde (37% solution). The development was stopped with 1% v/v acetic acid, and the gels were washed three times in water.
Quantitative analysis of digitized images was carried out using the PDQuest (version 7.0, BioRad) software according to the protocols provided by the manufacturer. Quantity of each spot was normalized by total valid spot intensity. Protein spots with intensity changed over two folds compared with control samples were selected for further studies.
Enzymatic digestion of protein in-gel
Protein spots were enzymatically digested in-gel similar to that described by Shevchenko et al  but modified using porcine trypsin. Gel pieces were washed with 50% acetonitrile to remove SDS, salt and stain, dried to remove solvent and then rehydrated in Trypsin (8-10 ng/μl) Digest Solution and incubated 8-10 h at 37°C. The proteolytic reaction was terminated by addition of 5 μl 0.5% trifluoroacetic acid. Tryptic peptides were recovered by combining the aqueous phase from several extractions of gel pieces with 50% aqueous acetonitrile. After concentration the peptide mixture was desalted using C18ZipTips (Millipore), and peptides eluted in 1 to 5 μl of acetonitrile. An aliquot of this solution was mixed with an equal volume of a saturated solution of a-cyano-4-hydroxycinnamic acid in 50% aqueous acetonitrile, and 1 μl of mixture spotted onto a target plate.
MALDI-TOF analysis and database search
Protein analysis was performed using an Ettan MALDI-TOF (Amersham Biosciences). Peptides were evaporated with a N2 laser at 337 nm, and using a delayed extraction approach. They were accelerated with 20 Kv injection pulse for time of flight analysis. Each spectrum was the cumulative average of 300 laser shots. The search program ProFound, developed by The Rockefeller University http://184.108.40.206/profound_bin/WebProFound.exe was used for protein identification by peptide mass fingerprinting. Spectra were calibrated with trypsin auto-digestion ion peak m/z (842.510, 2211.1046) as internal standards.
Cell lysates were prepared by using lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Triton X-100, 0.1% SDS, 1 mM EDTA, 1 mM Na3VO4, 1 mM NaF, 1× protease inhibitor cocktail). The extracts were incubated on ice, spun at 14,000× g for 20 min at 4°C and the supernatants were collected. Protein concentrations were determined by Bradford assay (Bio-Rad), and the protein (50-100 μg) was separated by electrophoresis on 4-12% NuPAGE Bis-Tris gels (Novex). Proteins were then transferred to Hybond ECL transfer membranes to evaluate their expression using PGM3 (Santa Cruz Biotechnologies) and β-actin (Sigma) antibodies.
Apoptotic cell death was examined by using DeadEnd™fluorometric TUNEL assay kit as described in the manufacturer's instructions. Briefly, cells were plated onto the poly-L-lysine-coated slides, fixed with 4% paraformaldehyde for 15 min and incubated in TdT enzyme buffer containing fluorescein-12-dUTP for 1 h at 37°C. After mounting in medium containing DAPI (Vectashield, Vector Labs), cells were visualized under a Carl Zeiss LSM5 confocal microscope.
Cells were transiently transfected with PGM3 or control siRNA (Santa Cruz Biotechnology, Santa Cruz, CA) at 50 nM of final concentration by using INTERFERin siRNA transfection reagent (Polyplus transfection) for 72 h.
Total RNA was prepared using the Trizol reagent (Invitorgen) following the manufacturer's instructions and reverse transcribed to cDNA using oligo-dT and random primers. The cDNA was amplified by PCR using the following specific primers:
PGM3: forward 5'-ACACGCCAAGCCCAATGGACT- 3',
GAPDH: forward 5'-TCACCATCTTCCAGGAGCGA-3'
PCR conditions were as follows: 92°C for 2 min; 94°C for 30 sec, 59°C for 30 sec, 72°C for 30 sec (30 cycles); and 72°C for 5 min. The amplified products were separated on 2% agarose gels.
All data were expressed as means ± SD. The statistically significant differences between control and SFN treated group were calculated by the Student's t- test.
This work was supported by the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korea government (MEST) (No. 2009-0063466).
- Golstein P, Kroemer G: Cell death by necrosis: towards a molecular definition. Trends Biochem Sci 2007, 32: 37–43. 10.1016/j.tibs.2006.11.001PubMedView ArticleGoogle Scholar
- Kerr JF, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972, 26: 239–257.PubMed CentralPubMedView ArticleGoogle Scholar
- Wyllie AH, Kerr JF, Currie AR: Cell death: the significance of apoptosis. Int Rev Cytol 1980, 68: 251–306. 10.1016/S0074-7696(08)62312-8PubMedView ArticleGoogle Scholar
- Landis SH, Murray T, Bolden S, Wingo PA: Cancer statistics, 1999. CA Cancer J Clin 1999, 49: 8–31. 10.3322/canjclin.49.1.8PubMedView ArticleGoogle Scholar
- Kumar R, Srinivasan S, Koduru S, Pahari P, Rohr J, Kyprianou N, Damodaran C: Psoralidin, an herbal molecule, inhibits phosphatidylinositol 3-kinase-mediated Akt signaling in androgen-independent prostate cancer cells. Cancer Prev Res (Phila Pa) 2009, 2: 234–243.View ArticleGoogle Scholar
- Seo SI, Gera L, Zhau HE, Qian WP, Iqbal S, Johnson NA, Zhang S, Zayzafoon M, Stewart J, Wang R, et al.: BKM1740, an acyl-tyrosine bisphosphonate amide derivative, inhibits the bone metastatic growth of human prostate cancer cells by inducing apoptosis. Clin Cancer Res 2008, 14: 6198–6206. 10.1158/1078-0432.CCR-08-1023PubMedView ArticleGoogle Scholar
- Thirugnanam S, Xu L, Ramaswamy K, Gnanasekar M: Glycyrrhizin induces apoptosis in prostate cancer cell lines DU-145 and LNCaP. Oncol Rep 2008, 20: 1387–1392.PubMedGoogle Scholar
- Zhou J, Duan L, Chen H, Ren X, Zhang Z, Zhou F, Liu J, Pei D, Ding K: Atovaquone derivatives as potent cytotoxic and apoptosis inducing agents. Bioorg Med Chem Lett 2009, 19: 5091–5094. 10.1016/j.bmcl.2009.07.044PubMedView ArticleGoogle Scholar
- Zhou Y, Liu YE, Cao J, Zeng G, Shen C, Li Y, Zhou M, Chen Y, Pu W, Potters L, Shi YE: Vitexins, nature-derived lignan compounds, induce apoptosis and suppress tumor growth. Clin Cancer Res 2009, 15: 5161–5169. 10.1158/1078-0432.CCR-09-0661PubMed CentralPubMedView ArticleGoogle Scholar
- Zhang Y, Talalay P, Cho CG, Posner GH: A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc Natl Acad Sci USA 1992, 89: 2399–2403. 10.1073/pnas.89.6.2399PubMed CentralPubMedView ArticleGoogle Scholar
- Cho SD, Li G, Hu H, Jiang C, Kang KS, Lee YS, Kim SH, Lu J: Involvement of c-Jun N-terminal kinase in G2/M arrest and caspase-mediated apoptosis induced by sulforaphane in DU145 prostate cancer cells. Nutr Cancer 2005, 52: 213–224. 10.1207/s15327914nc5202_11PubMedView ArticleGoogle Scholar
- Choi S, Lew KL, Xiao H, Herman-Antosiewicz A, Xiao D, Brown CK, Singh SV: D,L-Sulforaphane-induced cell death in human prostate cancer cells is regulated by inhibitor of apoptosis family proteins and Apaf-1. Carcinogenesis 2007, 28: 151–162. 10.1093/carcin/bgl144PubMedView ArticleGoogle Scholar
- Franceschi S, Favero A, La Vecchia C, Negri E, Dal Maso L, Salvini S, Decarli A, Giacosa A: Influence of food groups and food diversity on breast cancer risk in Italy. Int J Cancer 1995, 63: 785–789. 10.1002/ijc.2910630606PubMedView ArticleGoogle Scholar
- Franceschi S, Parpinel M, La Vecchia C, Favero A, Talamini R, Negri E: Role of different types of vegetables and fruit in the prevention of cancer of the colon, rectum, and breast. Epidemiology 1998, 9: 338–341. 10.1097/00001648-199805000-00020PubMedView ArticleGoogle Scholar
- Freudenheim JL, Marshall JR, Vena JE, Laughlin R, Brasure JR, Swanson MK, Nemoto T, Graham S: Premenopausal breast cancer risk and intake of vegetables, fruits, and related nutrients. J Natl Cancer Inst 1996, 88: 340–348. 10.1093/jnci/88.6.340PubMedView ArticleGoogle Scholar
- Heber D, Bowerman S: Applying science to changing dietary patterns. J Nutr 2001, 131: 3078S-3081S.PubMedGoogle Scholar
- Verhoeven DT, Goldbohm RA, van Poppel G, Verhagen H, van den Brandt PA: Epidemiological studies on brassica vegetables and cancer risk. Cancer Epidemiol Biomarkers Prev 1996, 5: 733–748.PubMedGoogle Scholar
- Chung FL, Conaway CC, Rao CV, Reddy BS: Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate. Carcinogenesis 2000, 21: 2287–2291. 10.1093/carcin/21.12.2287PubMedView ArticleGoogle Scholar
- Fahey JW, Zhang Y, Talalay P: Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc Natl Acad Sci USA 1997, 94: 10367–10372. 10.1073/pnas.94.19.10367PubMed CentralPubMedView ArticleGoogle Scholar
- Zhang Y, Kensler TW, Cho CG, Posner GH, Talalay P: Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proc Natl Acad Sci USA 1994, 91: 3147–3150. 10.1073/pnas.91.8.3147PubMed CentralPubMedView ArticleGoogle Scholar
- Singh AV, Xiao D, Lew KL, Dhir R, Singh SV: Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo. Carcinogenesis 2004, 25: 83–90. 10.1093/carcin/bgg178PubMedView ArticleGoogle Scholar
- Chiao JW, Chung FL, Kancherla R, Ahmed T, Mittelman A, Conaway CC: Sulforaphane and its metabolite mediate growth arrest and apoptosis in human prostate cancer cells. Int J Oncol 2002, 20: 631–636.PubMedGoogle Scholar
- Fimognari C, Nusse M, Cesari R, Iori R, Cantelli-Forti G, Hrelia P: Growth inhibition, cell-cycle arrest and apoptosis in human T-cell leukemia by the isothiocyanate sulforaphane. Carcinogenesis 2002, 23: 581–586. 10.1093/carcin/23.4.581PubMedView ArticleGoogle Scholar
- Gamet-Payrastre L, Li P, Lumeau S, Cassar G, Dupont MA, Chevolleau S, Gasc N, Tulliez J, Terce F: Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res 2000, 60: 1426–1433.PubMedGoogle Scholar
- Gingras D, Gendron M, Boivin D, Moghrabi A, Theoret Y, Beliveau R: Induction of medulloblastoma cell apoptosis by sulforaphane, a dietary anticarcinogen from Brassica vegetables. Cancer Lett 2004, 203: 35–43. 10.1016/j.canlet.2003.08.025PubMedView ArticleGoogle Scholar
- Jackson SJ, Singletary KW: Sulforaphane: a naturally occurring mammary carcinoma mitotic inhibitor, which disrupts tubulin polymerization. Carcinogenesis 2004, 25: 219–227. 10.1093/carcin/bgg192PubMedView ArticleGoogle Scholar
- Cohen JH, Kristal AR, Stanford JL: Fruit and vegetable intakes and prostate cancer risk. J Natl Cancer Inst 2000, 92: 61–68. 10.1093/jnci/92.1.61PubMedView ArticleGoogle Scholar
- Giovannucci E, Rimm EB, Liu Y, Stampfer MJ, Willett WC, Yoshizawa K, Ascherio A, Morris JS, Baskett CK, Chen J, et al.: A prospective study of cruciferous vegetables and prostate cancer. Cancer Epidemiol Biomarkers Prev 2003, 12: 1403–1409.PubMedGoogle Scholar
- Kolonel LN, Hankin JH, Whittemore AS, Wu AH, Gallagher RP, Wilkens LR, John EM, Howe GR, Dreon DM, West DW, Paffenbarger RS Jr: Vegetables, fruits, legumes and prostate cancer: a multiethnic case-control study. Cancer Epidemiol Biomarkers Prev 2000, 9: 795–804.PubMedGoogle Scholar
- Kristal AR, Lampe JW: Brassica vegetables and prostate cancer risk: a review of the epidemiological evidence. Nutr Cancer 2002, 42: 1–9. 10.1207/S15327914NC421_1PubMedView ArticleGoogle Scholar
- Herman-Antosiewicz A, Xiao H, Lew KL, Singh SV: Induction of p21 protein protects against sulforaphane-induced mitotic arrest in LNCaP human prostate cancer cell line. Mol Cancer Ther 2007, 6: 1673–1681. 10.1158/1535-7163.MCT-06-0807PubMedView ArticleGoogle Scholar
- Shankar S, Ganapathy S, Srivastava RK: Sulforaphane enhances the therapeutic potential of TRAIL in prostate cancer orthotopic model through regulation of apoptosis, metastasis, and angiogenesis. Clin Cancer Res 2008, 14: 6855–6866. 10.1158/1078-0432.CCR-08-0903PubMedView ArticleGoogle Scholar
- Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M: Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 2006, 127: 635–648. 10.1016/j.cell.2006.09.026PubMedView ArticleGoogle Scholar
- Stein CA: Mechanisms of action of taxanes in prostate cancer. Semin Oncol 1999, 26: 3–7.PubMedGoogle Scholar
- Gan PP, Kavallaris M: Tubulin-targeted drug action: functional significance of class ii and class IVb beta-tubulin in vinca alkaloid sensitivity. Cancer Res 2008, 68: 9817–9824. 10.1158/0008-5472.CAN-08-1501PubMedView ArticleGoogle Scholar
- van der Loop FT, Schaart G, Timmer ED, Ramaekers FC, van Eys GJ: Smoothelin, a novel cytoskeletal protein specific for smooth muscle cells. J Cell Biol 1996, 134: 401–411. 10.1083/jcb.134.2.401PubMedView ArticleGoogle Scholar
- van der Veer E, Nong Z, O'Neil C, Urquhart B, Freeman D, Pickering JG: Pre-B-cell colony-enhancing factor regulates NAD+-dependent protein deacetylase activity and promotes vascular smooth muscle cell maturation. Circ Res 2005, 97: 25–34. 10.1161/01.RES.0000173298.38808.27PubMedView ArticleGoogle Scholar
- Pang H, Koda Y, Soejima M, Kimura H: Identification of human phosphoglucomutase 3 (PGM3) as N-acetylglucosamine-phosphate mutase (AGM1). Ann Hum Genet 2002, 66: 139–144. 10.1046/j.1469-1809.2002.00103.xPubMedView ArticleGoogle Scholar
- Bruckheimer EM, Kyprianou N: Apoptosis in prostate carcinogenesis. A growth regulator and a therapeutic target. Cell Tissue Res 2000, 301: 153–162. 10.1007/s004410000196PubMedView ArticleGoogle Scholar
- Harkonen P: Androgenic control of glycolysis, the pentose cycle and pyruvate dehydrogenase in the rat ventral prostate. J Steroid Biochem 1981, 14: 1075–1084. 10.1016/0022-4731(81)90219-3PubMedView ArticleGoogle Scholar
- Gasper AV, Al-Janobi A, Smith JA, Bacon JR, Fortun P, Atherton C, Taylor MA, Hawkey CJ, Barrett DA, Mithen RF: Glutathione S-transferase M1 polymorphism and metabolism of sulforaphane from standard and high-glucosinolate broccoli. Am J Clin Nutr 2005, 82: 1283–1291.PubMedGoogle Scholar
- Pledgie-Tracy A, Sobolewski MD, Davidson NE: Sulforaphane induces cell type-specific apoptosis in human breast cancer cell lines. Mol Cancer Ther 2007, 6: 1013–1021. 10.1158/1535-7163.MCT-06-0494PubMedView ArticleGoogle Scholar
- Jost LM, Kirkwood JM, Whiteside TL: Improved short- and long-term XTT-based colorimetric cellular cytotoxicity assay for melanoma and other tumor cells. J Immunol Methods 1992, 147: 153–165.PubMedView ArticleGoogle Scholar
- Shevchenko A, Wilm M, Vorm O, Mann M: Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996, 68: 850–858. 10.1021/ac950914hPubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<url>http://creativecommons.org/licenses/by/2.0</url>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.